Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293940 · ClinicalTrials.gov registry record · NA
Cryoablation for Post Mastectomy Pain Syndrome
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03293940 is a NA study that has completed, run by Emory University. The registered enrollment target is 35 participants.
The verdict
NCT03293940, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a prospective, randomized, parallel-group, treatment control trial with cross-over options performed at four sites. The purpose of this study is to assess the efficacy and safety of cryoablation therapy for the treatment of post mastectomy pain syndrome.
Interventions
- PROCEDURE Cryoablation
- PROCEDURE Therapeutic Peripheral Nerve Block (tPNB) Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2021-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03293940
The ClinicalTrials.gov registry entry for NCT03293940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cryoablation is the first listed.
NCT03293940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03293940 about?
NCT03293940 is a clinical study titled "Cryoablation for Post Mastectomy Pain Syndrome". This is a prospective, randomized, parallel-group, treatment control trial with cross-over options performed at four sites. The purpose of this study is to assess the efficacy and safety of cryoablation therapy for the treatment of post mastectomy pain syndrome.
What is the current status of trial NCT03293940?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-01-10. Estimated completion is 2021-05-19.
What interventions are being tested in trial NCT03293940?
The interventions under investigation include: Cryoablation (PROCEDURE), Therapeutic Peripheral Nerve Block (tPNB) Injection (PROCEDURE).
Who is sponsoring clinical trial NCT03293940?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.